GLUT1 and GLUT3 in brain glucose metabolism: mechanisms, regulation, and implications for metabolic disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review of molecular mechanisms and physiological pathways without primary human data
PubMed 41405816 · doi:10.1007/s11011-025-01753-0
What was done
This review synthesized literature on the physiological roles and molecular regulation of the primary brain glucose transporters, GLUT1 (parenchymal glucose delivery) and GLUT3 (neuronal glucose uptake). The authors examined how pathological conditions (ischemia, hypoxia, oxidative stress, neuroinflammation) affect transporter expression and activity, and summarized key regulatory signaling pathways, including PI3K/Akt, HIF-1α, AMPK, mTOR, microRNAs, and their molecular crosstalk.
What was found
No empirical numbers or quantitative effect sizes were reported in the abstract. The review summarized that GLUT1 and GLUT3 expression and activity are dynamically modulated across physiological and disease states via interconnected signaling networks, specifically highlighting the involvement of PI3K/Akt, mTOR, HIF-1α, and AMPK coupling.
Why it matters
Understanding the regulatory networks controlling brain glucose transporters clarifies the mechanistic basis of neuroenergetic impairment and highlights potential molecular targets for metabolic and neurological disorders.
Limits
As a narrative review, it presents no original experimental data, systematic search protocol, or meta-analytic quantification. The abstract notes that significant gaps remain in establishing direct causal links between upstream regulatory signaling, real-time transporter dynamics, and measurable clinical therapeutic outcomes.
Cited by
- supports Glucose is the primary fuel source for human cells, especially brain cells.